ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
about
Colposcopic triage methods for detecting cervical intraepithelial neoplasia grade 3 after cytopathological diagnosis of low-grade squamous intraepithelial lesion: a systematic review on diagnostic testsHPV for cervical cancer screening: is the era of the molecular pap smear upon us?Performance of cytology and human papillomavirus testing in relation to the menstrual cycle.Description of patients with squamous cell carcinoma in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study.POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women.Human papillomavirus testing using hybrid capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method.Investigating CBIR techniques for cervicographic images.Shape priors for segmentation of the cervix region within uterine cervix images.A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study.A unified set of analysis tools for uterine cervix image segmentation.Content-Based Image Retrieval in Medicine: Retrospective Assessment, State of the Art, and Future Directions.Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.Challenges and Recommendations to Recruiting Women Who Do Not Adhere to Follow-Up Gynecological Care.Impact of improved classification on the association of human papillomavirus with cervical precancer.Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfectionHuman papillomavirus genotypes in cervical intraepithelial neoplasia grade 3Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesionsRelationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load.The accuracy of colposcopic grading for detection of high-grade cervical intraepithelial neoplasia.Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study.Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinantsLineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage studyRisk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment.Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection.Multiple biopsies and detection of cervical cancer precursors at colposcopy.Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control studyHuman papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infectionsEarly cervical neoplasia: advances in screening and treatment modalities.Evaluation of a new DNA test for detection of carcinogenic human papillomavirus.Detection of precancerous cervical lesions is differential by human papillomavirus type.Adherence and retention in clinical trials: a community-based approachThe clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.Evaluation of any or type-specific persistence of high-risk human papillomavirus for detecting cervical precancer.Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancerProtective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status.HPV-DNA testing for cervical cancer precursors: from evidence to clinical practiceAssociation of Human Papillomavirus 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage.Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.
P2860
Q26863434-A4E20F4B-BDD0-45B9-AE32-DE109EF2C216Q30307753-C8C32F80-22B2-406B-80B3-1A6E7AA3EB60Q30438635-6306F39D-F5B5-4300-902C-A5EECC1F738EQ30440400-BAF60E62-E44C-4914-8343-AB08869CF5B3Q30917882-CCB13280-82A2-4E4A-BF55-4ED931A61F6FQ31075135-8B2A9170-ABBB-4727-A895-44FF0DA71E05Q33359187-BA8A1BE2-6938-41A3-8CD5-7017E95EBF3CQ33360307-7FC31AA0-01EA-4225-8988-A0DD640D1D4AQ33580897-2F059436-1DC1-4889-B7A0-26CB0515B579Q33590357-5DE1A838-2CF7-4F43-BEF1-8C9286728CBAQ33594413-0BC56E09-0DBF-48E6-A504-FDAC4C3B8538Q33684754-F9153891-7891-494B-9CB3-7329F61A659DQ33823793-7B18DE14-04B7-46DE-B33B-D709EB1D14C1Q33883581-7EA2D66C-A9C2-40BE-90B7-8ECFE0088198Q33947813-7AD6460A-9FED-4EE5-8CD7-806AA2879FB5Q33984185-CCD47F18-183C-4210-B808-F16C609FA929Q34055574-D4F00B65-58E6-43CD-9BB5-915F3ABC94F1Q34062235-AB2F96B6-1261-45EA-BBA1-F303CE904BA1Q34065016-6B4C2AAA-7107-418C-824E-125CBA6943A9Q34093282-5FECEB4A-7032-491F-8066-288812E06419Q34187446-C9B8E6B0-0247-4431-91A0-AAC60C04B62CQ34209101-BABDF4B3-39CC-4D8E-9CE9-BBAFF980C8D8Q34268415-E94EDFC1-D947-4B6A-8EE0-1A7768C7202FQ34636306-B020DF4F-C634-4CB9-BE11-9A8EAAFFB030Q34714582-4E153647-1638-4B2D-9188-911BA542FCF0Q34716608-54D394E8-D4BD-4A5B-82F7-F29DDABA9E31Q34834113-E0374301-4EB3-4767-B103-A94BE3D9BC9CQ35022779-BA71ED43-50AD-4066-9DE7-2998CE1A4C0DQ35049980-3A3F30E5-DEC1-43A6-A6BA-2BB2B9B964ECQ35139772-1938A092-E26C-4DD3-9ACB-83D80ED6A099Q35163630-1B384546-03D2-4200-BCF2-33669C01D6BFQ35560412-90AE942B-C061-4988-A706-3FDB41714B23Q35588255-ADAA2A48-A726-40F8-B1BC-12CF36995AD5Q35689055-34023291-FDA9-4960-9E4B-586DAEE86D1AQ35867432-97094C76-BDBA-4DFB-9440-43E209F12356Q36069771-FC5309A2-1555-43D1-84BD-6B13822109B3Q36071760-D3827D74-536B-4E54-A39D-9BA2904BCFCEQ36174016-2E110F6C-9592-4F99-A185-C7E19348211FQ36301217-57D67126-ECDA-4037-8F6D-207FD52D8692Q36404994-7A490DCF-33D4-44AE-BCD7-E0311DB64A3B
P2860
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
@en
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
@nl
type
label
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
@en
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
@nl
prefLabel
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
@en
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
@nl
P356
P1433
P1476
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.
@en
P2093
Adrianza ME
Schiffman M
P304
P356
10.1159/000328554
P577
2000-09-01T00:00:00Z